EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Inhibition of VEGF signaling prevents exhaustion and enhances anti-leukemia efficacy of CAR-T cells via Wnt/β-catenin pathway

Suwan Wu, Yiyi Wei, Yingqi Qiu, Kexin Ai, Mu Chen, Hao Wang, Honghao Zhang, Qingyan Cen, Peiyun Liao, Xiangyang Ding, Xiaoling Xie, Yuhua Li iD

Journal of Translational Medicine · 2025-04-30 · 23 (1)

DOI: 10.1186/s12967-024-05907-z ↗

At a glance

Journal article in Journal of Translational Medicine, published online on 2025-04-30. Written by Suwan Wu and 11 co-authors. Institution: Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Major MEDLINE topics: Wnt Signaling Pathway, Vascular Endothelial Growth Factor A, Receptors, Chimeric Antigen, T-Lymphocytes. Cited 13 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

BACKGROUND: Current challenges in Chimeric Antigen Receptor (CAR) -T cell therapy for hematological cancers include T cell exhaustion and limited persistence, which contribute to cancer relapse. METHODS: The effects of Axitinib, a VEGFR inhibitor, on the biological functions of CAR-T cells in vitro and in vivo were investigated by comparing CAR-T cells pre-treated ex vivo with Axitinib, as well as utilizing a B-ALL mouse model. Real-time quantitative PCR and Western blotting were employed to detect the expression of molecules related to differentiation, exhaustion, and the Wnt pathway in CAR-T cells. Flow cytometry was used to assess changes in CAR-T cell differentiation, exhaustion, activation, apoptosis, proliferation, and cytokine secretion. Western blotting and flow cytometry were used to assess changes in VEGFR expression. Bioluminescence imaging, flow cytometry, and immunohistochemistry (IHC) analysis were used to evaluate changes in tumor burden in mice receiving different treatments, while hematoxylin and eosin (H&E) staining were used to monitor histological changes in the liver and spleen of mice. RESULTS: Axitinib treatment notably reduced CAR-T cell exhaustion and terminal differentiation both under tonic signaling and tumor antigen exposure scenarios. Furthermore, CAR-T cells pretreated with Axitinib demonstrated enhanced anti-tumor efficacy and prolonged survival in vivo. Mechanistically, Axitinib treatment upregulated the Wnt/β-catenin signaling pathway in CAR-T cells. Using agonists/inhibitors of the Wnt/β-catenin pathway could respectively mimic or counteract the effects of Axitinib on CAR-T cell exhaustion and differentiation. CAR-T cells treated with Axitinib can inhibit the VEGFR2 pathway. CAR-T cells treated with anti-VEGFR2 antibody can activate the Wnt/β-catenin pathway and prevent CAR-T cell exhaustion. CONCLUSION: Axitinib confers resistance to exhaustion in CAR-T cells by modulating the Wnt/β-catenin signaling pathway.

Subjects

MeSH terms (MEDLINE)

Wnt Signaling PathwayVascular Endothelial Growth Factor AReceptors, Chimeric AntigenT-LymphocytesImmunotherapy, AdoptiveAnimalsAxitinibHumansCell Line, TumorMiceApoptosisCell ProliferationCell Differentiation

Author keywords

Acute lymphoblastic leukemiaChimeric antigen receptor T cellsDifferentiationExhaustionVascular endothelial growth factor receptor

Substances

AxitinibVascular Endothelial Growth Factor AReceptors, Chimeric Antigen

Authors and institutions

  • Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. xx1413@smu.edu.cn.
  • Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. liyuhua1974@outlook.com.
  • Bioland laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, China. liyuhua1974@outlook.com.

ORCID profiles: Yuhua Li

Funding

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Cite

APA

Wu, S., Wei, Y., Qiu, Y., Ai, K., Chen, M., Wang, H., Zhang, H., Cen, Q., Liao, P., Ding, X., Xie, X., & Li, Y. (2025). Inhibition of VEGF signaling prevents exhaustion and enhances anti-leukemia efficacy of CAR-T cells via Wnt/β-catenin pathway. Journal of Translational Medicine, 23(1). https://doi.org/10.1186/s12967-024-05907-z

Vancouver

Wu S, Wei Y, Qiu Y, Ai K, Chen M, Wang H, et al. Inhibition of VEGF signaling prevents exhaustion and enhances anti-leukemia efficacy of CAR-T cells via Wnt/β-catenin pathway. Journal of Translational Medicine. 2025;23(1). doi:10.1186/s12967-024-05907-z

BibTeX
@article{Wu2025,
  author = {Wu, Suwan and Wei, Yiyi and Qiu, Yingqi and Ai, Kexin and Chen, Mu and Wang, Hao and Zhang, Honghao and Cen, Qingyan and Liao, Peiyun and Ding, Xiangyang and Xie, Xiaoling and Li, Yuhua},
  title = {Inhibition of VEGF signaling prevents exhaustion and enhances anti-leukemia efficacy of CAR-T cells via Wnt/β-catenin pathway},
  journal = {Journal of Translational Medicine},
  year = {2025},
  volume = {23},
  number = {1},
  doi = {10.1186/s12967-024-05907-z}
}
Start for free →